openPR Logo
Press release

Global Antidepressant Drugs Market Size, Share, Analysis, Industry Report and Forecast 2019-2025

12-09-2020 10:42 AM CET | Health & Medicine

Press release from: ORION MARKET RESEARCH

Global Antidepressant Drugs Market Size, Share, Analysis,

The global antidepressant drug market is expected to grow at a significant CAGR during the forecast period. Antidepressants are used for the treatment of all age group patients suffering from clinical and anxiety depression and are further used for regulating mood. As per the Centers for Disease Control and Prevention (CDC), during the period, 2011–2014, 12.7% of people aged 12 and overtook antidepressant medication. This, in turn, reflects the increasing demand for antidepressant drugs in the market.

Based on the drug class, the antidepressant drugs market is segmented into selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), atypical antidepressants, monoamine oxidase inhibitors (MAOIs), and other medications. SSRIs segment held a significant share in the global antidepressant drug market.

Request a Free Sample of our Global Antidepressant Drugs Market : https://www.omrglobal.com/request-sample/antidepressant-drugs-market

SSRIs aim to relieve symptoms that work by blocking the reuptake, or reabsorption, of serotonin by some brain nerve cells. It increases the serotonin level in the brain, which improves mood. SSRIs drugs include sertraline, escitalopram, citalopram, fluoxetine, and paroxetine, usually produced at least side effects, as compared to tricyclic antidepressants. The common side effects of these drugs comprise sexual dysfunction, sleepiness or insomnia, and weight gain. These types of drugs are considered a potential treatment for all kinds of anxiety disorders; however, the treatment of OCD normally requires higher doses.

SNRIs class include duloxetine and venlafaxine, which is known for its dual mechanism of action, such as enhancing the levels of the norepinephrine and neurotransmitters serotonin by constraining their reabsorption into brain cells. Like other medications, its possible side effects include a minor increase in blood pressure, headache, stomach upset, insomnia, sexual dysfunction, and weight gain. Such medications are considered as potential as SSRIs, and therefore, it is also considered as a first-line treatment to treat anxiety disorders. However, it is not preferred for OCD, where SSRIs are usually chosen as a first-line treatment.

However, antidepressants may trigger hypomania or mania in some people. If the patient stops taking the antidepressant, it can worsen bipolar symptoms. In this case, the patient may be given a new diagnosis and different medication. Several other side-effects that are associated with antidepressants include neuroleptic malignant syndrome, suicidal feelings, SIADH (Syndrome of Inappropriate Antidiuretic Hormone Secretion), and serotonin syndrome. Due to these concerns, major pharmaceutical companies, including GSK, AstraZeneca, Pfizer, Merck, and Sanofi slowed researches on new antidepressants altogether. This, in turn, results in slowing down the adoption rate and the overall antidepressant drug market.

A full Report of Global Antidepressant Drugs Market is Available at: https://www.omrglobal.com/industry-reports/antidepressant-drugs-market

Global Antidepressant Drugs Market – Segmentation

By Depressive Disorder

Major Depressive Disorder (MDD)

Obsessive-compulsive Disorder (OCD)

Generalized Anxiety Disorder (GAD)

Panic Disorder (PD)

Other Depressive Disorders

By Drug Class

Selective Serotonin Reuptake Inhibitors (SSRIs)

Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)

Atypical Antidepressants

Monoamine Oxidase Inhibitors (MAOIs)

Other Medications

Global Antidepressant Drugs Market – Segmentation by Region

North America

United States

Canada

Europe

Germany

United Kingdom

France

Spain

Italy

Rest of Europe

Asia-Pacific

China

Japan

India

Rest of Asia-Pacific

Rest of the World

Company Profiles

Alkermes Plc

Allergan PLC

Breckenridge Pharmaceutical, Inc.

AstraZeneca Plc

Bristol Myers Squibb Co.

Camber Pharmaceutical Inc.

Eli Lilly & Co.

GlaxoSmithKline Plc

H. Lundbeck A/S

Intellipharmaceutics International Inc.

Johnson & Johnson Services Inc.

Merck & Co., Inc.

Mylan N.V.

7.14.Novartis International AG

Pfizer Inc.

Sanofi S.A.

Sun Pharmaceuticals Ltd.

Takeda Pharmaceutical Co.

Teva Pharmaceutical Industries Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/antidepressant-drugs-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Antidepressant Drugs Market Size, Share, Analysis, Industry Report and Forecast 2019-2025 here

News-ID: 2205452 • Views:

More Releases from ORION MARKET RESEARCH

Road Marking Paint Market : A Guide to Understanding the Process
Road Marking Paint Market : A Guide to Understanding the Process
The Road Marking Paint Market, valued at approximately USD 5.02 billion in 2023, is projected to reach around USD 7.69 billion by 2033, growing at a compound annual growth rate (CAGR) of 4.36% from 2024 to 2033. Road Marking Paint Market Overview The Road Marking Paint Market is steadily expanding, driven by burgeoning infrastructure investments and the need for improved road safety. Governments and municipalities are increasingly allocating funds toward both new
Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Gr …
The Outboard Boats Market, valued at approximately USD 5.74 billion in 2023, is projected to grow to around USD 14 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 9% over the 2024-2033 period. Outboard Boat Market Overview The Outboard Boat Market continues to expand robustly, fueled largely by rising demand for recreational boating, favorable economic conditions, and the appeal of leisure marine activities. Innovations in outboard motor technology-including
Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and …
The Mobile Ticketing Market, valued at about USD 2.9 billion in 2023, is anticipated to grow to approximately USD 11.39 billion by 2033, reflecting a robust CAGR of 16.7% from 2024 to 2033. Mobile Ticketing Market Overview The Mobile Ticketing Market is undergoing rapid expansion, driven primarily by the global surge in smartphone usage and consumer preference for contactless, digital experiences. This growth is further propelled by widespread adoption of digital payments,
Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Grow …
The Metal Alloy Market, valued at approximately USD 301.7 billion in 2023, is projected to reach USD 533.9 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2033. Metal Alloy Market Overview The Metal Alloy Market is experiencing steady, long-term expansion, driven by growing demand from key sectors such as automotive, aerospace, construction, and electronics. Applications in next-generation vehicles and aircraft are pushing interest in

All 5 Releases


More Releases for Antidepressant

Antidepressant Drugs Market is Dazzling Worldwide and Forecast to 2031
The global antidepressant drug market is expected to grow at a significant CAGR during the forecast period. Antidepressants are used for the treatment of all age group patients suffering from clinical and anxiety depression and are further used for regulating mood. As per the Centers for Disease Control and Prevention (CDC), during the period, 2011-2014, 12.7% of people aged 12 and overtook antidepressant medication. This, in turn, reflects the increasing
Antidepressant Drugs Market to Witness Astonishing Growth by 2029
The global antidepressant drug market is expected to grow at a significant CAGR during the forecast period. Antidepressants are used for the treatment of all age group patients suffering from clinical and anxiety depression and are further used for regulating mood. As per the Centers for Disease Control and Prevention (CDC), during the period, 2011-2014, 12.7% of people aged 12 and overtook antidepressant medication. This, in turn, reflects the increasing demand for
Antidepressant Drugs Market to Encounter Countless Growth Opportunities by 2028
The depression is the mood disorder that give a continue feeling of sadness and loss of interest. There are many factors which leads to the depression such as inherited traits, hormones, stress, brain chemistry which can cause the depression. The antidepressants help to maintain the balance between the brain chemistry and hormonal changes which is used for treatment of depression. Depression require long time of treatment it can be treated
Stakeholders: Antidepressant Drugs Market boom in Coming Year
The global antidepressant drugs market is estimated to surpass $18,762.4 million by 2027, exhibiting a CAGR of 2.9% from 2020 to 2027. OFFERINGS OF THE REPORT: The report offers comprehensive analysis of the global antidepressant drugs market by thoroughly studying different aspects of the market including major segments, market statistics, market dynamics, regional market outlook, investment opportunities, and top players working towards the growth of the market. The report also sheds light on
Antidepressant Drugs Market Analysis and Advancements Outlook 2019 - 2025
The report titled "Antidepressant Drugs Market" report will be very useful to get a stronger and effective business outlook. It provides an in-depth analysis of different attributes of industries such as trends, SWOT analysis, policies, and clients operating in several regions. The qualitative and quantitative analysis techniques have been used by analysts to provide accurate and applicable data to the readers, business owners and industry experts. The Antidepressant Drugs market was
Antidepressant Drugs market ready to register a 3.12 % CAGR
Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report. Executive Summary -: A comprehensive research report that analyses the Antidepressant Drugs Market and the drugs market by Class - Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Benzodiazepines, Antipsychotics and Novel Agents, the report also assesses the sales of antidepressant drugs by sales channels - Hospital & Clinics, Retail Pharmacies, Others. A